Distinguished in Congenital Lipoid Adrenal Hyperplasia

Noriyuki Katsumata

Yokosuka, JP 
Distinguished in Congenital Lipoid Adrenal Hyperplasia
Yokosuka, JP 
OverviewLocationsClinical Research

Overview

Noriyuki Katsumata practices in Yokosuka, Japan. Katsumata is rated as a Distinguished expert by MediFind in the treatment of Congenital Lipoid Adrenal Hyperplasia. Their top areas of expertise are Hyperglycerolemia, Congenital Lipoid Adrenal Hyperplasia, Familial Glucocorticoid Deficiency, Ovarian Cancer, and Hysterectomy.

Their clinical research consists of co-authoring 190 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Congenital Lipoid Adrenal Hyperplasia.

Locations

Yokosuka, Japan
Other Locations
Kawasaki, 2118533, Japan
Kanagawa, Japan
Tokyo, 1578535, Japan
Department Of Head And Neck Surgery, Yokohama, Japan
Zama, 2528583, Japan
Setagaya, 1578535, Japan
Japan
Kashiwa, Japan
Saitama, Japan
Chuo, Japan
Chuo, 1040045, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Tisotumab Vedotin, Topotecan, Vinorelbine, Gemcitabine, Irinotecan, Pemetrexed
Study Phase: Phase 3

190 Total Publications

High-Dose Corticosteroid Therapy in Facial Nerve Palsy: A Retrospective Study.
High-Dose Corticosteroid Therapy in Facial Nerve Palsy: A Retrospective Study.
Journal: Cureus
Published: April 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Katsumata's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile